Outcome of Board Meeting
IOL Chemicals & Pharmaceuticals Ltd has informed BSE that Mr. Yogesh Goel, Independent Director and Mr. Ravi Pratap Singh, Independent Director, have tendered resignations from the directorship of the Company which were accepted by the Board of Directors in its meeting held on May 14, 2016. The Board appreciated the services rendered by them during their tenure as directors of the Company. Results Press Release for March 31, 2016
IOL Chemicals & Pharmaceuticals Ltd has informed BSE about : 1. Result Press Release for the period ended March 31, 2016 Standalone Financial Results, Form A, Auditors Report for March 31, 2016
IOL Chemicals & Pharmaceuticals Ltd has informed BSE about : 1. Standalone Financial Results for the period ended March 31, 20162. Standalone Form A for the period ended March 31, 20163. Standalone Auditors Report for the period ended March 31, 2016 Board Intimation for Results & Closure of Trading Window
IOL Chemicals & Pharmaceuticals Ltd has informed BSE that the meeting of the Board of Directors is scheduled to be held on May 02, 2016, inter alia, to consider and approve the audited financial results of the Company for the quarter and the financial year ended March 31, 2016.Further, in terms of provisions of the Company's Code of Conduct to Regulate, Monitor and Report Trading by Insiders, the "Trading Window" of the Company shall remain... Updates
IOL Chemicals & Pharmaceuticals Ltd has informed BSE regarding "Notice U/s 201 of the Companies Act, 2013 - Newspaper Clippings". Statement of Investor Complaint under Reg. 13(3) of SEBI (LODR) Regulations, 2015 for Quarter ended March 31, 2016
IOL Chemicals & Pharmaceuticals Ltd has informed BSE regarding Quarterly Statement on Investor Complaints / Grievances Redressal Mechanism for the Quarter ended March 31, 2016, under Regulation 13(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Shareholding for the Period Ended March 31, 2016
IOL Chemicals & Pharmaceuticals Ltd has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2016. For more details, kindly Click here Outcome of Independent Directors Meeting
IOL Chemicals & Pharmaceuticals Ltd has informed BSE that Independent Directors of the Company at its meeting held on March 29, 2016, inter alia, reviewed the performance of Non-Independent Directors and the Board as a whole; reviewed the performance of the Chairman of the Company and assessed the quality, quantity and timeliness of flow of information between the Company management and the Board in line with the requirement of regulation 25 of the... Certificates of Pharmaceuticals Products (COPP) confirming WHO guidelines
IOL Chemicals & Pharmaceuticals Ltd has informed BSE regarding "Certificates of Pharmaceuticals Products (COPP) confirming WHO guidelines".